About DBIS   | Story archive   | Contact DBIS  | DBIS home

Diagnosing Alzheimer's Early

Neurologists, Imaging Scientists Use Medical Physics to Spot Disease in Blood Vessels

May 1, 2006

A new brain-imaging method allows physicians to diagnose Alzheimer's before its onset. A radioactive dye is injected in the blood and travels to the brain, where it attaches to plaque deposits of amyloid, a protein believed to cause Alzheimer's. The dye makes amyloid plaque look yellow in a Positron Emission Tomography (PET) scan.

read the full story...

Science Insider

Science behind the news is funded by a generous grant from the NSF

BACKGROUND: A novel imaging agent has the potential to diagnose Alzheimer's disease in living patients by binding to the telltale beta-amyloid deposits in the brains of those who suffer from it. Called Pittsburgh Compound-B, or PIB, the contrast agent is used in conjunction with PET scans. This non-invasive technique can give researchers information never before available about how and where the disease progresses in the brain, as well as the efficacy of treatment.

WHAT THEY'VE FOUND: The pattern of PIB retention in the brain suggests that amyloid plaques formed by Alzheimers appearing first in the frontal cortex areas, then progressing to the parietal and temporal cortex before ravaging the occipital and sensory-motor cortex. This may explain why memory and judgment are often the brain functions first affected with the onset of the disease.

ABOUT ALZHEIMER'S: Alzheimer's is the most common form of dementia, a brain disorder that primarily affects the elderly. Scientists still aren't sure what causes the disease, and there is no cure. It is named after a German doctor, Alois Alzheimer, who noticed (in 1906) anomalies in the brain tissue of a woman who had died of a strange mental illness. There were abnormal clumps (called amyloid plaques) and tangled bundles of fibers, both of which are the most common signs of Alzheimer's. Other brain changes can occur. Nerve cells die in areas of the brain vital to memory and other mental abilities, and the connections between nerve cells are disrupted, impairing thinking and memory.

SYMPTOMS: Alzheimer's is a slow-moving disease, and in its earliest stages, may merely appear to be mild forgetfulness, and confused with age-related memory change. There may be problems remembering recent events or activities, or the names of familiar people or objects. As the disease progresses, the forgetfulness becomes more severe, interfering with daily activities, such as brushing one's teeth. There are problems speaking, understanding, reading or writing, and eventually the brain damage becomes so severe as to require total care.

Video help

Latest stories

  • A Satellite Named Violet and a Student Named Amanda
  • Behind the Scenes with the K-Team
  • Deep Space Discoveries
  • Dogs Fighting Cancer
  • Earthquake! What's Your Risk

Did you know?...

As many as 4.5 million Americans suffer from Alzheimer's disease. While only about 5 percent of men and women aged 65-74 have the disease, nearly half of those 85 or older may have it.

More information on this story

Dr. William Klunk
University of Pittsburgh Medical Center
Pittsburgh, PA
Tel: 412-647-8762 or 1-800-533-8762
upmcweb@upmc.edu


© 2011 American Institute of Physics